EXAMINE-CAD-DZHK22: First prospective randomized trial to examine a differential therapeutic response in symptomatic patients with non-obstructive coronary artery disease after coronary physiological testing
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Project leader | Ulf Landmesser |
| Site | Berlin |
| Project type | Klinische Studie |
| Funding | € 868.101,00 |
| Begin | 15.08.2020 |
| End | 31.03.2024 |
Förderkennzeichen
81X1100223
Projektnummer
1220